Literature DB >> 2707762

Langerhans cells in human lung tumours: an immunohistological study.

S B Fox1, M Jones, M S Dunnill, K C Gatter, D Y Mason.   

Abstract

In an immunocytochemical study of 41 human lung tumours we have shown that Langerhans cells can be reliably identified using the anti-CD1 monoclonal antibody NA1/34. Langerhans cells are present in all the main varieties of human lung tumour although they are infrequent in both small cell carcinoma and carcinoid tumour. There is considerable variation in numbers of Langerhans cells in both adenocarcinomas and squamous cell carcinomas. In this study tumours were divided into those with high numbers of Langerhans cells (greater than 2 per high power field) and those with low numbers (less than 2 per high power field). Analysing these results against patient survival showed a markedly worse survival in those tumours with a high number of Langerhans cells for all the tumours as a single group and for squamous cell carcinoma as a single entity.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2707762     DOI: 10.1111/j.1365-2559.1989.tb02145.x

Source DB:  PubMed          Journal:  Histopathology        ISSN: 0309-0167            Impact factor:   5.087


  4 in total

1.  Immunohistochemical characterization of HLA-DR-antigen positive dendritic cells in phaeochromocytomas and paragangliomas as a prognostic marker.

Authors:  M Furihata; Y Ohtsuki
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1991

2.  Evidence that granulocyte macrophage-colony-stimulating factor regulates the distribution and differentiated state of dendritic cells/Langerhans cells in human lung and lung cancers.

Authors:  A Tazi; F Bouchonnet; M Grandsaigne; L Boumsell; A J Hance; P Soler
Journal:  J Clin Invest       Date:  1993-02       Impact factor: 14.808

3.  An immunohistochemical investigation of diagnostic biopsy material taken from short and long term survivors with small cell lung cancer.

Authors:  L G Bobrow; F R Hirsch; F G Hay; L Happerfield; B G Skov; K Law; R C Leonard; R L Souhami
Journal:  Br J Cancer       Date:  1992-09       Impact factor: 7.640

4.  CD1a-positive infiltrating-dendritic cell density and 5-year survival from human breast cancer.

Authors:  B J Coventry; J Morton
Journal:  Br J Cancer       Date:  2003-08-04       Impact factor: 7.640

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.